Invention Grant
US07824860B2 Application of aprataxin gene to diagnosis and treatment for early-onset spinocerebellar ataxia (EAOH)
有权
应用aprataxin基因诊断和治疗早发性脊髓小脑性共济失调（EAOH）
- Patent Title: Application of aprataxin gene to diagnosis and treatment for early-onset spinocerebellar ataxia (EAOH)
- Patent Title (中): 应用aprataxin基因诊断和治疗早发性脊髓小脑性共济失调（EAOH）
-
Application No.: US11496284Application Date: 2006-07-31
-
Publication No.: US07824860B2Publication Date: 2010-11-02
- Inventor: Shoji Tsuji
- Applicant: Shoji Tsuji
- Applicant Address: US MA Worcester
- Assignee: Athena Diagnostics, Inc.
- Current Assignee: Athena Diagnostics, Inc.
- Current Assignee Address: US MA Worcester
- Agency: Hamilton, Brook, Smith, Reynolds, P.C.
- Priority: JP2001-279719 20010914
- Main IPC: C07H21/04
- IPC: C07H21/04 ; C12Q1/68
Abstract:
The present invention provides polynucleotides and proteins, which are involved in early-onset spinocerebellar ataxia with ocular motor apraxia and hypoalbuminemia (EAOH); and methods of using the polynucleotides and/or proteins to treat and/or diagnose EAOH.
Public/Granted literature
- US20060292622A1 Application of aprataxin gene to diagnosis and treatment for early-onset spinocerebellar ataxia (EAOH) Public/Granted day:2006-12-28
Information query
